• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Novartis receives binding offer from Siemens Healthineers for molecular imaging business

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 25, 2024 at 11:12: PM
via Swiss drugmaker Novartis (NOVN.S) said on Saturday it had received a binding offer from Germany's Siemens Healthineers (SHLG.DE) to acquire its molecular imaging business for Fluorine-18 positron emission tomography, or PET scans.

article source
 




Top Bottom
Back
Quote